The Food and Drug Administration has granted tentative approval for Basaglar (insulin glargine injection), which is used to improve glycemic control in adults with Type 2 diabetes and in combination with mealtime insulin in adults and pediatric patients with Type 1 diabetes.
Nearly half of women age 45 years or older who experience symptoms of overactive bladder report their current treatment does not address their OAB symptoms, according to a recent survey conducted by The Harris Poll on behalf of Allergan.
Recurrence of hormone-related breast cancer was cut by half in overweight and obese women who regularly used aspirin or other nonsteroidal anti-inflammatory drugs, according to data published last week in Cancer Research, a journal of the American Association for Cancer Research.
High-dose influenza vaccine is 24% more effective than the standard-dose vaccine in protecting persons ages 65 and older against influenza illness and its complications, according to a Vanderbilt-led study published Wednesday in the New England Journal of Medicine.
Sanofi on Monday acquired the rights to Afrezza Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with Type 1 and Type 2 diabetes, from MannKind in a deal that could be worth as much as $925 million.
Michael Taylor, who currently serves as the Food and Drug Administration's deputy commissioner for foods and veterinary medicine, outlined the importance for companies to adhere to gluten-free guidelines in a post on FDA Voice.
New York City's Department of Health and Mental Hygiene said a man who was tested for Ebola at Mount Sinai Hospital is "unlikely" to have the virus. The patient was admitted to the hospital early Monday with a fever and gastrointestinal problems. He recently visited a West African country where Ebola was reported, according to the Washington Post.
A new study published in the July issue of the Journal of Bone and Mineral Research found no increased risk of coronary heart disease or all-cause mortality in post-menopausal women supplementing with calcium and vitamin D.
Sam's Club on Wednesday announced that it is offering DNA testing and fingerprint kits as a part of their annual free children's health screenings, both standard tools for personal identification that can be useful for parents should they ever be needed, on Saturday, Aug. 9.
The Food and Drug Administration on Thursday announced the approval of Ruconest, a recombinant C1-Esterase inhibitor product for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema.
Wahl Home Products has teamed up with GreaterGood.org to promote the One Picture Saves a Life Campaign, a collaboration among pet industry leaders to change public perceptions about rescued animals and provide grooming and photography resources to shelters.
HelpAround on Wednesday launched a mobile platform for people with diabetes — and their friends, family and caregivers — that reveals fellow ‘diabetes helpers’ from the crowd, helping people resolve sudden health crises, such as getting caught without essential over-the-counter blood glucose test strips.